Hansa Biopharma AB (publ)
SSE:HNSA.ST
32.64 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 732.06 | 1,496.179 | 651.342 | 1,139.362 | 181.697 | 439.441 | 581.078 | 213.588 | 175.683 | 10.152 | 0.09 | 18.966 | 1.157 | 0.222 | 0.612 | 5.917 |
Short Term Investments
| 0 | 0 | 237.619 | 238.144 | 419.397 | 418.746 | 34.983 | 39.99 | 0 | 0 | -2.064 | 0.262 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 732.06 | 1,496.179 | 888.961 | 1,377.506 | 601.094 | 858.187 | 616.061 | 253.578 | 175.683 | 10.152 | 0.09 | 18.966 | 1.157 | 0.222 | 0.612 | 5.917 |
Net Receivables
| 91.756 | 107.551 | 20.958 | 6.943 | 5.257 | 7.104 | 7.801 | 2.748 | 0.625 | 0.229 | 0.808 | 1.743 | 0 | 0 | 0 | 0 |
Inventory
| 9.792 | 0.973 | 0.242 | 0.098 | -0.001 | -7.104 | -7.801 | -2.748 | 0 | -0.229 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 21.543 | 0.001 | 20.889 | 5.716 | 9.393 | 8.033 | 8.121 | 3.404 | 2.613 | 1.798 | 1.834 | 2.412 | 1.751 | 1.201 | 1.188 | 1.783 |
Total Current Assets
| 855.151 | 1,604.704 | 942.342 | 1,393.387 | 615.743 | 866.22 | 624.182 | 256.982 | 178.296 | 11.95 | 1.924 | 21.379 | 2.908 | 1.422 | 1.8 | 7.699 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 27.073 | 35.836 | 45.784 | 9.7 | 15.144 | 5.876 | 3.976 | 2.57 | 2.182 | 1.283 | 0.115 | 0.199 | 0.313 | 0.406 | 0.114 | 0.141 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 135.817 | 46.866 | 28.761 | 31.41 | 33.348 | 33.197 | 33.749 | 36.554 | 36.327 | 36.898 | 40.421 | 40.369 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 135.817 | 46.866 | 28.761 | 31.41 | 33.348 | 33.197 | 33.749 | 36.554 | 36.327 | 36.898 | 40.421 | 40.369 | 37.675 | 35.973 | 36.233 | 37.026 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | -379.218 | -16.475 | -25.424 | 7.283 | 4.18 | 10.381 | 3.59 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.283 | -4.18 | -10.381 | -3.59 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | -4.079 | -0.001 | 0.001 | 418.746 | 34.983 | 39.99 | 7.283 | 4.18 | 8.317 | 3.852 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 162.89 | 82.702 | 70.466 | 41.109 | 48.493 | 78.601 | 56.233 | 53.69 | 45.792 | 42.361 | 48.852 | 44.42 | 37.988 | 36.379 | 36.347 | 37.167 |
Total Assets
| 1,018.041 | 1,687.406 | 1,012.808 | 1,434.496 | 664.236 | 944.821 | 680.415 | 310.672 | 224.088 | 54.311 | 50.777 | 65.798 | 40.896 | 37.801 | 38.147 | 44.866 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 86.966 | 62.476 | 53.36 | 26.669 | 50.573 | 40.426 | 3.771 | 6.482 | 1 | 1.795 | 0.71 | 0.84 | 0 | 0 | 0 | 0 |
Short Term Debt
| 7.503 | 7.165 | 6.888 | 4.415 | 4.632 | 0.101 | 0.403 | 0.044 | 0.042 | 0.039 | 0.519 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 1.599 | 0.762 | 0.19 | 0.134 | 0.319 | 0 | 0 | 0.084 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 41.473 | 40.43 | 24.961 | 83.121 | 0 | 31.698 | -0.403 | 0.084 | 0 | 0 | 3.513 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 185.046 | 154.642 | 86.01 | -0.002 | 39.335 | 0.106 | 39.827 | 19.122 | 11.471 | 2.582 | 0.355 | 1.716 | 6.189 | 5.635 | 5.226 | 4.132 |
Total Current Liabilities
| 320.988 | 264.713 | 171.219 | 114.203 | 94.54 | 72.331 | 43.598 | 25.732 | 12.513 | 4.416 | 5.097 | 2.556 | 6.189 | 5.635 | 5.226 | 4.132 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 844.903 | 783.927 | 28.491 | 0.63 | 4.827 | 0.476 | 0 | 0.004 | 0.049 | 0.091 | 0.131 | 0 | 0 | 0 | 8 | 0 |
Deferred Revenue Non-Current
| 14.362 | 29.5 | 47.02 | 62.026 | 0.818 | 10.948 | 0 | 0.114 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0.367 | 0.405 | 0.426 | 0.424 | 0.507 | 0.511 | 0.538 | 0.581 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 5.297 | 5.949 | 8.079 | 15.089 | 0.729 | 0.679 | 5.618 | 0.548 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 864.929 | 819.781 | 84.016 | 78.169 | 6.881 | 12.614 | 6.156 | 1.247 | 0.049 | 0.091 | 0.131 | 0 | 0 | 0 | 8 | 0 |
Total Liabilities
| 1,185.917 | 1,084.494 | 255.235 | 192.372 | 101.421 | 84.945 | 49.754 | 26.979 | 12.562 | 4.507 | 5.097 | 2.556 | 6.189 | 5.635 | 13.226 | 4.132 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0.137 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 55.034 | 55.034 | 46.335 | 45.895 | 41.448 | 40.682 | 38.208 | 35.055 | 32.412 | 25.93 | 22.225 | 22.225 | 0 | 0 | 19.316 | 19.316 |
Retained Earnings
| -3,302.807 | -2,471.087 | -1,859.953 | -1,311.671 | -971.821 | -611.491 | -363.517 | -186.857 | -75.728 | -9.462 | -17.562 | -16.466 | 0 | 0 | -9.289 | 6.523 |
Accumulated Other Comprehensive Income/Loss
| -0.408 | 0.013 | 0.127 | -0.137 | 81.163 | 31.216 | 9.801 | 6.288 | 1.624 | 0 | 2.064 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 3,080.305 | 3,018.952 | 2,571.064 | 2,507.9 | 1,412.025 | 1,399.469 | 946.169 | 429.207 | 253.218 | 33.336 | 38.953 | 57.483 | 34.707 | 32.166 | 14.895 | 14.895 |
Total Shareholders Equity
| -167.876 | 602.912 | 757.573 | 1,242.124 | 562.815 | 859.876 | 630.661 | 283.693 | 211.526 | 49.804 | 45.68 | 63.242 | 34.707 | 32.166 | 24.921 | 40.734 |
Total Equity
| -167.876 | 602.912 | 757.573 | 1,242.124 | 562.815 | 859.876 | 630.661 | 283.693 | 211.526 | 49.804 | 45.68 | 63.242 | 34.707 | 32.166 | 24.921 | 40.734 |
Total Liabilities & Shareholders Equity
| 1,018.041 | 1,687.406 | 1,012.808 | 1,434.496 | 664.236 | 944.821 | 680.415 | 310.672 | 224.088 | 54.311 | 50.777 | 65.798 | 40.896 | 37.801 | 38.147 | 44.866 |